Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery

BACKGROUND: There is a concern that HER2-directed systemic therapies, when administered concurrently with stereotactic radiosurgery (SRS), may increase the risk of radiation necrosis (RN). This study explores the impact of timing and type of systemic therapies on the development of RN in patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Christine, Buckley, Evan D., Van Swearingen, Amanda E. D., Giles, Will, Herndon, James E., Kirkpatrick, John P., Anders, Carey K., Floyd, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163666/
https://www.ncbi.nlm.nih.gov/pubmed/35669439
http://dx.doi.org/10.3389/fonc.2022.854364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163666/
https://www.ncbi.nlm.nih.gov/pubmed/35669439
http://dx.doi.org/10.3389/fonc.2022.854364

Ejemplares similares